Terms: = Prostate cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
29 results:
1. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity.
Ronchi S; Cicchetti A; Bonora M; Ingargiola R; Camarda AM; Russo S; Imparato S; Castelnuovo P; Pasquini E; Nicolai P; Ansarin M; Del Vecchio M; Benazzo M; Orlandi E; Vischioni B
Radiother Oncol; 2024 Jan; 190():110003. PubMed ID: 37956889
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of metabolism-associated molecular patterns in prostate cancer.
Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
Oh JH; Lee S; Thor M; Rosenstein BS; Tannenbaum A; Kerns S; Deasy JO
Radiother Oncol; 2023 Aug; 185():109723. PubMed ID: 37244355
[TBL] [Abstract] [Full Text] [Related]
4. Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
Tsumura H; Tanaka N; Oguchi T; Owari T; Nakai Y; Asakawa I; Iijima K; Kato H; Hashida I; Tabata KI; Satoh T; Ishiyama H
Radiat Oncol; 2022 Apr; 17(1):71. PubMed ID: 35410307
[TBL] [Abstract] [Full Text] [Related]
5. Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Guren MG; Haug ES; Naume B; Schlichting E; Møller B
BMC Cancer; 2022 Feb; 22(1):220. PubMed ID: 35227226
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
Grechko N; Skarbova V; Tomaszewska-Kiecana M; Ramlau R; Centkowski P; Drew Y; Dziadziuszko R; Zemanova M; Beltman J; Nash E; Habeck J; Liao M; Xiao J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):259-270. PubMed ID: 33909097
[TBL] [Abstract] [Full Text] [Related]
7. Differences in Use of Aggressive Therapy for Localized prostate cancer in New York City.
Smigelski M; Wallace BK; Lu J; Li G; Anderson CB
Clin Genitourin Cancer; 2021 Feb; 19(1):e55-e62. PubMed ID: 32891565
[TBL] [Abstract] [Full Text] [Related]
8. Deep learning applications in automatic needle segmentation in ultrasound-guided prostate brachytherapy.
Wang F; Xing L; Bagshaw H; Buyyounouski M; Han B
Med Phys; 2020 Sep; 47(9):3797-3805. PubMed ID: 32542758
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.
Lu Y; Huang HH; Lau WKO
World J Urol; 2020 Jan; 38(1):103-109. PubMed ID: 30953141
[TBL] [Abstract] [Full Text] [Related]
10. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
Gershman B; Maroni P; Tilburt JC; Volk RJ; Konety B; Bennett CL; Kutikov A; Smaldone MC; Chen V; Kim SP
World J Urol; 2019 Oct; 37(10):2099-2108. PubMed ID: 30671637
[TBL] [Abstract] [Full Text] [Related]
11. The importance of sexuality, changes in erectile functioning and its association with self-esteem in men with localized prostate cancer: data from an observational study.
Hilger C; Schostak M; Neubauer S; Magheli A; Fydrich T; Burkert S; Kendel F
BMC Urol; 2019 Jan; 19(1):9. PubMed ID: 30665424
[TBL] [Abstract] [Full Text] [Related]
12. Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer.
Gilbert R; Tilling K; Martin RM; Lane JA; Davis M; Hamdy FC; Neal DE; Donovan JL; Metcalfe C
Cancer Causes Control; 2018 Mar; 29(3):383-388. PubMed ID: 29453511
[TBL] [Abstract] [Full Text] [Related]
13. prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.
Klein Nulent TJW; van Es RJJ; Krijger GC; de Bree R; Willems SM; de Keizer B
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1614-1621. PubMed ID: 28593386
[TBL] [Abstract] [Full Text] [Related]
14. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
[TBL] [Abstract] [Full Text] [Related]
15. Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.
Morgan TM; Hawken SR; Ghani KR; Miller DC; Feng FY; Linsell SM; Salisz JA; Gao Y; Montie JE; Cher ML
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):216-21. PubMed ID: 26951715
[TBL] [Abstract] [Full Text] [Related]
16. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
Tevaarwerk AJ; Lee JW; Terhaar A; Sesto ME; Smith ML; Cleeland CS; Fisch MJ
Cancer; 2016 Feb; 122(3):438-46. PubMed ID: 26687819
[TBL] [Abstract] [Full Text] [Related]
17. prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.
Patel HD; Feng Z; Landis P; Trock BJ; Epstein JI; Carter HB
J Urol; 2014 Mar; 191(3):629-37. PubMed ID: 24060641
[TBL] [Abstract] [Full Text] [Related]
18. The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.
Kachroo N; Gnanapragasam VJ
J Cancer Res Clin Oncol; 2013 Jan; 139(1):1-24. PubMed ID: 23187933
[TBL] [Abstract] [Full Text] [Related]
19. Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.
Nix JW; Turkbey B; Hoang A; Volkin D; Yerram N; Chua C; Linehan WM; Wood B; Choyke P; Pinto PA
BJU Int; 2012 Dec; 110(11 Pt B):E694-700. PubMed ID: 23035719
[TBL] [Abstract] [Full Text] [Related]
20. Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells.
Kim YI; Shim J; Kim BH; Lee SJ; Lee HK; Cho C; Cho BN
Int J Oncol; 2012 Aug; 41(2):690-700. PubMed ID: 22581369
[TBL] [Abstract] [Full Text] [Related]
[Next]
